Tenet Healthcare Corporation (THC) stock experienced a significant drop of 6.86% in the pre-market session on Wednesday. The healthcare company reported its fourth-quarter 2024 financial results, which fell short of analysts' expectations on the revenue front, potentially contributing to the stock's plummet.
According to the earnings report, Tenet Healthcare's revenue for the quarter declined 5.7% year-over-year to $5.07 billion, missing the consensus estimate of $5.17 billion. The company attributed the revenue decline to the divestiture of 14 hospitals in the previous year.
Additionally, Tenet Healthcare's outlook for fiscal year 2025 failed to impress investors. The company forecasted revenue in the range of $20.6 billion to $21 billion, lower than analysts' expectations of $21.25 billion. While the company's adjusted earnings per share guidance of $11.74 to $12.84 exceeded analysts' estimates of $11.42, the disappointing revenue outlook appears to have overshadowed the positive earnings guidance.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。